Infrastructure Capital Advisors LLC acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 26,324 shares of the company’s stock, valued at approximately $3,383,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Gables Capital Management Inc. purchased a new position in Merck KGaA in the 2nd quarter worth $2,095,000. Diversify Advisory Services LLC bought a new stake in Merck KGaA in the second quarter worth $3,810,000. Danske Bank A S purchased a new stake in Merck KGaA during the second quarter valued at about $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new stake in Merck KGaA during the second quarter valued at about $25,541,000. Finally, BOK Financial Private Wealth Inc. purchased a new stake in Merck KGaA during the second quarter valued at about $523,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of OTCMKTS:MKGAF opened at $163.21 on Monday. The stock has a market capitalization of $21.09 billion, a P/E ratio of 24.92 and a beta of 0.96. The stock’s 50-day moving average price is $162.62 and its 200-day moving average price is $148.44. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
